Dr. Lopez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2400 Pratt St
Ste 1100
Durham, NC 27705Phone+1 919-668-1002Fax+1 919-668-1091
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1989 - 1991- Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1989 - 1990
Stanford University School of MedicineClass of 1989
Certifications & Licensure
CA State Medical License 1991 - Present
NC State Medical License 2013 - 2025
AL State Medical License 1999 - 2013
GA State Medical License 1996 - 1999- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 10 citationsRisk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center...R Martino, R Lopez, A Sureda, S Brunet, A Domingo-Albós
Haematologica. 1997-05-01 - 42 citationsPreclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiformeN. L. Bryant, G. Yancey Gillespie, Richard D. Lopez, James M. Markert, Gretchen A. Cloud
Journal of Neuro-Oncology. 2011-01-01 - 79 citationsEX VIVO EXPANDED HUMAN Vλ9Vδ2+ λδ-T CELLS MEDIATE INNATE ANTITUMOR ACTIVITY AGAINST HUMAN PROSTATE CANCER CELLS IN VITROZhiyong Liu, Ben L. Guo, Bradley Gehrs, L.I. Nan, Richard D. Lopez
The Journal of Urology. 2005-05-01
Abstracts/Posters
- Evaluation of the Oral SYK Inhibitor Fostamatinib in Patients after Allogeneic Transplantation for Chronic Graft-Versus-Host DiseaseRichard D. Lopez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Geriatric Assessment Identifies Impairments in Younger Candidates for Allogeneic Hematopoietic Stem Cell TransplantationRichard D. Lopez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Decreased Mortality after the First Year of Allogeneic Hematopoietic Stem Cell Transplant in Recipients of Umbilical Cord Blood Vs. Matched Related or Matched Unrelate...Richard D. Lopez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Grant Support
- Therapeutic Antitumor And Antiviral Potential Of Allogeneic Gamma-Delta T CellsNational Institute Of Allergy And Infectious Diseases2010–2011
- Gamma Delta T Cell Immunotherapy Of Breast CancerNational Cancer Institute2007–2011
- Gamma Delta T Cells--Immunotherapy For MelanomaNational Cancer Institute2002–2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
